|
| 36194072 | A revision to the United States national ALS registry's algorithm to improve Case-Ascertainment. | Amyotroph Lateral Scler Frontotemporal Degener | 2023 |
| 37539949 | Comparing Amyotrophic lateral sclerosis (ALS) patient characteristics from the National ALS Registry and the Massachusetts ALS Registry, data through 2015. | Amyotroph Lateral Scler Frontotemporal Degener | 2023 |
| 37494887 | Amyotrophic Lateral Sclerosis-Bulbar Dysfunction Index-Remote: Test-Retest and Interrater Reliability of Candidate Items. | Am J Speech Lang Pathol | 2023 |
| 37345437 | Resilient together-ALS: leveraging the NDD transdiagnostic framework to develop an early dyadic intervention for people with amyotrophic lateral sclerosis and their informal care-partners. | Amyotroph Lateral Scler Frontotemporal Degener | 2023 |
| 37245090 | Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis. | Ann Neurol | 2023 |
| 37043596 | A roadmap for early psychosocial support in palliative care for people impacted by ALS-reducing suffering, building resiliency, and setting the stage for delivering timely transdiagnostic psychosocial care. | Transl Behav Med | 2023 |
| 36789434 | A fluid biomarker reveals loss of TDP-43 splicing repression in pre-symptomatic ALS. | bioRxiv | 2023 |
| 36748473 | Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review. | Amyotroph Lateral Scler Frontotemporal Degener | 2023 |
| 36879025 | Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures. | NPJ Digit Med | 2023 |
| 36686519 | Face and content validation of the amyotrophic lateral sclerosis-Bulbar dysfunction index (ALS-BDI). | Front Neurol | 2023 |
| 36840949 | Randomized trial of inosine for urate elevation in amyotrophic lateral sclerosis. | Muscle Nerve | 2023 |
| 36802910 | Acoustic Measures of Dysphonia in Amyotrophic Lateral Sclerosis. | J Speech Lang Hear Res | 2023 |
| 36929648 | Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS). | Muscle Nerve | 2023 |
| 36106817 | Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS. | Amyotroph Lateral Scler Frontotemporal Degener | 2023 |
| 34779076 | Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid. | Brain Pathol | 2022 |
| 35765222 | An expanded access protocol of RT001 in amyotrophic lateral sclerosis-Initial experience with a lipid peroxidation inhibitor. | Muscle Nerve | 2022 |
| 35577511 | Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial. | J Neurol Neurosurg Psychiatry | 2022 |
| 35623334 | Validity of Off-the-Shelf Automatic Speech Recognition for Assessing Speech Intelligibility and Speech Severity in Speakers With Amyotrophic Lateral Sclerosis. | J Speech Lang Hear Res | 2022 |
| 36454749 | Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of <i>C9orf72</i> disease. | Proc Natl Acad Sci U S A | 2022 |
| 36251310 | Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A Review. | JAMA Neurol | 2022 |
| 35904151 | Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis. | Muscle Nerve | 2022 |
| 36038262 | Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2022 |
| 36305960 | The efficacy of acoustic-based articulatory phenotyping for characterizing and classifying four divergent neurodegenerative diseases using sequential motion rates. | J Neural Transm (Vienna) | 2022 |
| 36127362 | Rate of speech decline in individuals with amyotrophic lateral sclerosis. | Sci Rep | 2022 |
| 35958519 | Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis. | EClinicalMedicine | 2022 |
| 36053951 | Antibody Response to HML-2 May Be Protective in Amyotrophic Lateral Sclerosis. | Ann Neurol | 2022 |
| 36121612 | Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents. | Drugs | 2022 |
| 35014217 | A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS. | Ann Clin Transl Neurol | 2022 |
| 34890069 | A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis. | Muscle Nerve | 2022 |
| 35276083 | Excessive release of inorganic polyphosphate by ALS/FTD astrocytes causes non-cell-autonomous toxicity to motoneurons. | Neuron | 2022 |
| 35119373 | Using Smartphones to Reduce Research Burden in a Neurodegenerative Population and Assessing Participant Adherence: A Randomized Clinical Trial and Two Observational Studies. | JMIR Mhealth Uhealth | 2022 |
| 34935174 | Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development. | Ann Neurol | 2022 |
| 35115730 | Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines. | Nat Neurosci | 2022 |
| 35171700 | Validating Automatic Diadochokinesis Analysis Methods Across Dysarthria Severity and Syllable Task in Amyotrophic Lateral Sclerosis. | J Speech Lang Hear Res | 2022 |
| 35260465 | Protocol for psychometric evaluation of the Amyotrophic Lateral Sclerosis - Bulbar Dysfunction Index (ALS-BDI): a prospective longitudinal study. | BMJ Open | 2022 |
| 34757590 | Targeting Tau Mitigates Mitochondrial Fragmentation and Oxidative Stress in Amyotrophic Lateral Sclerosis. | Mol Neurobiol | 2022 |
| 32744050 | Exploring the use of educational materials for increasing participation in a stretching program: a quality improvement project in people with motor neuron disease. | Eur J Phys Rehabil Med | 2021 |
| 33771057 | Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale. | Amyotroph Lateral Scler Frontotemporal Degener | 2021 |
| 33646879 | In Traditional Medicare, Modest Growth In The Home Care Workforce Largely Driven By Nurse Practitioners. | Health Aff (Millwood) | 2021 |
| 34878988 | Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry's Research Notification Mechanism. | J Med Internet Res | 2021 |
| 34762814 | "You Say Severe, I Say Mild": Toward an Empirical Classification of Dysarthria Severity. | J Speech Lang Hear Res | 2021 |
| 34714698 | Co-Occurrence of Hypernasality and Voice Impairment in Amyotrophic Lateral Sclerosis: Acoustic Quantification. | J Speech Lang Hear Res | 2021 |
| 34476128 | Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design. | Neurol Clin Pract | 2021 |
| 34220673 | Two Distinct Clinical Phenotypes of Bulbar Motor Impairment in Amyotrophic Lateral Sclerosis. | Front Neurol | 2021 |
| 34016561 | Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial. | Neuroimage Clin | 2021 |
| 34348539 | Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic. | Amyotroph Lateral Scler Frontotemporal Degener | 2021 |
| 34348533 | Single breath counting is an effective screening tool for forced vital capacity in ALS. | Amyotroph Lateral Scler Frontotemporal Degener | 2021 |
| 34153344 | Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact. | Neurosci Biobehav Rev | 2021 |
| 33118628 | Smartphone data during the COVID-19 pandemic can quantify behavioral changes in people with ALS. | Muscle Nerve | 2021 |
| 33226425 | Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. | JAMA Neurol | 2021 |